All news is rigorously fact-checked and reviewed by leading blockchain experts and seasoned industry insiders.
- XRP’s real-world utility has grown quite a bit over the past decade, evolving into a key part of several payment and liquidity solutions.
- XRP is now in the health sector, after the Nasdaq‑listed Wellgistics launched its Ripple Labs-powered XRP Implementation Program.
Last month, Wellgistics Health (NASDAQ: WGRX), a tech-driven pharmaceutical distributor and AI-powered hub fulfillment company, unveiled its new XRP Implementation Program for independent pharmacies.
The integration is now happening, and it will run through RxERP, a serialized pharma eCommerce and ERP platform. Serving over 6,500 independent pharmacies and more than 200 manufacturers, Wellgistics is in a prime position to roll out XRP-powered payments on a large scale.
The benefits are clear: blockchain’s tamper-proof nature can help store and verify medical records, clinical trial data, and research findings, while XRP’s speed makes it ideal for cross-border healthcare payments, from paying overseas specialists to importing medical supplies or delivering aid.
Transactions on the XRP Ledger typically settle in just 3–5 seconds. Another major advantage? The ability to combat counterfeit drugs by tracking and verifying pharmaceuticals from manufacturer to patient, much like VeChain has done in its network.
Pro-XRP lawyer Bill Morgan spotlighted the initiative on X, noting the SEC filing details and calling out one key takeaway: “Wellgistics Health Integrates XRP for Faster, Cheaper Pharmacy Transactions.”
A Full-Stack XRP Integration
In line with Wellgistics’ announcement, we mentioned in our last update that on May 8, the company revealed plans to integrate XRP not just as a payment rail, but as a treasury reserve and liquidity tool. Backed by a $50 million equity line of credit, the company is building a real-time payments infrastructure around XRP.
In its S-1 filing with the Securities and Exchange Commission (SEC), Wellgistics outlined how it intends to leverage the XRP Ledger for invoice settlement, automated rebates, and cross-border payouts, while also using XRP as collateral or a liquidity reserve.
This is a concrete business-to-business (B2B) payments strategy designed to slash costs compared to traditional ACH or SWIFT systems.
In a July post, Bill Morgan called it a full-stack deployment of XRP across core operations, one that blends utility, capital efficiency, and market innovation. The company even plans to use its XRP holdings as collateral for financing and aims to generate income from XRP-based activities, underscoring its role beyond speculation. Wellgistics has also signaled it may raise capital through equity or debt to expand its XRP reserves.
Meanwhile, the XRP Ledger currently has a total value locked (TVL) of $84 million, per DefiLlama data. With XRP’s market cap sitting over 2,200 times its DeFi TVL, and a staggering 363,000 times its annualized fee revenue, the asset is still a giant in the space.
XRP is trading at $3.12, down 3.65% in the last 24 hours and 6.67% over the past week, but just 19% shy of its 2021 all-time high of $3.84. Growing chatter about the SEC potentially greenlighting a spot XRP Exchange Traded Fund (ETF) is adding fuel to bullish speculation, with many eyeing a break above $4.
The SEC has already opened proceedings on Cboe BZX’s proposal to list the Franklin XRP ETF, with a key decision window coming in this month.
